Blue Cross and Blue Shield of Kansas City (Blue KC) is grateful to all the healthcare providers who have been working tirelessly to take care of our community while being on the frontlines fighting the COVID-19 outbreak these last two and a half years
For the latest updated information on COVID-19 policies, over-the-counter testing guidelines, coding and billing, see the “COVID-19 Information” section on the home page of Providers.BlueKC.com.
Effective January 1, 2022, the Centers for Medicare and Medicaid Services (CMS) revised the description of existing place of service (POS) code 02 and created new POS code 10 to meet the overall insurance industry needs. Effective April 1, 2022, Blue KC modified its claims system to reflect this change.
Telehealth services billed by a provider with a POS code 02 is based on the Medicare fee schedule for telehealth services provided in a facility. The Medicare fee schedule for telehealth services provided in a facility is reimbursed at a lower amount than telehealth services provided in the patient’s home (POS code 10).
It is important providers use the correct coding guidelines published by CMS: POS code 02 is for telehealth provided other than in the patient’s home, while POS code 10 is for telehealth
provided in the patient’s home. When filing claims with POS code 02 or POS code 10 for telehealth, please remember to follow the correct coding guidelines.
For more details on Telehealth, visit the COVID-19 Information section on the home page of Providers.BlueKC.com.
Blue KC is pitching in to help KC Current Goalkeeper AD Franch give back to the KC community by “Playing for Trees”.
During September’s “Hunger Action Month”, Blue KC, a founding partner of the KC Current and the National Women’s Soccer League team’s official health insurance partner, is proud to announce we are donating $100 each time AD records a save in support of Franch’s “Playing for Trees” campaign, which partners with The Giving Grove to bring more orchards to neighborhoods in Kansas City.
Blue KC’s donations kicked off with the Current’s match on August 28 and will continue through the remainder of the 2022 season, including any postseason games. The donations are going directly to The Giving Grove, a Kansas City-based nonprofit that supports neighborhood volunteers in planting and caring for fruit trees, nut trees and berry brambles that improve the urban environment, increase tree canopy and provide a sustainable source of free, organically-grown food for neighborhoods facing high rates of food insecurity.
The Giving Grove is one of Blue KC’s Well Stocked partners. Founded in 2018, Blue KC’s Well Stocked initiative aims to increase food access and reduce food insecurity in Kansas City.
“Through Blue KC’s Well Stocked initiative and in conjunction with our Well Stocked partners, we’ve been working to improve access to healthy foods across the Kansas City area since 2018. We’re excited to support the Current, AD and The Giving Grove in their work to plant life-giving trees throughout our community.”
Macaela Stephenson, Director of Community Relations and Investments, Blue KC
Blue KC partnered with the Kansas City Royals, Carl’s Cause, Zero Reasons Why and other behavioral health and suicide prevention organizations to raise awareness for the 988 crisis number during the July 23 Royals game at Kauffman Stadium. One week earlier, the National Suicide Prevention Lifeline rolled out the new 988 crisis number, which is available for suicide prevention and mental health crisis.
This promotion was part of the Shut Out the Stigma initiative, Blue KC’s partnership with the Royals, to elevate the understanding in our community about the importance of behavioral health. Check out this powerful video about the 988 event with the Royals.
How to Check HMO Member’s PCP on ID Card
Like putting on your white laboratory coat or scrubs, we want the claims process to be one of the easiest things you do all day! To help avoid a claim denial, please make sure our HMO members are seeing the correct Primary Care Provider listed on their ID card. Here’s how to identify the correct PCP on our HMO ID cards:
Commercial HMO (PCP listed below Plan)
MA HMO (PCP listed below Group number)
Office of Inspector General Telemedicine Fraud Alert
Blue KC recently received the Office of Inspector General (OIG) Special Fraud Alert for Practitioners to exercise caution when entering into arrangements with Telemedicine Companies. Below are a few main takeaways that may be helpful to providers. Clickhere to access the direct link for the Alert:
- Fraud Scheme: Telemedicine Companies intentionally paid physicians and nonphysician practitioners kickbacks to generate orders or prescriptions for medically unnecessary durable medical equipment, genetic testing, wound care items or prescription medications, resulting in submissions of fraudulent claims to Medicare, Medicaid and other Federal healthcare programs.
- Concerns: These schemes raise concern because of the potential for considerable harm to Federal healthcare programs and their beneficiaries, which may include: (1) an inappropriate increase in costs to Federal healthcare programs for medically unnecessary items and services and, in some instances, items and services a beneficiary never receives; (2) potential to harm beneficiaries by, for example, providing medically unnecessary care, items that could harm a patient, or improperly delaying needed care; and (3) corruption of medical decision-making.
- Federal Laws Implicated: When a party knowingly and willfully pays remuneration to induce or reward referrals of items or services payable by a Federal healthcare program, the Federal anti-kickback statute is violated. By its terms, the statute ascribes liability to parties on both sides of an impermissible kickback transaction. Other laws implicated may include the OIG’s exclusion authority related to kickbacks, the Civil Monetary Penalties Law provision for kickbacks, the criminal healthcare fraud statute and the False Claims Act.
- The Practitioner does not have sufficient contact with or information from the purported patient to meaningfully assess the medical necessity of the items or services ordered or prescribed.
- The Telemedicine Company compensates the Practitioner based on the volume of items or services ordered or prescribed, which may be characterized to the Practitioner as compensation based on the number of purported medical records that the Practitioner reviewed.
- The Telemedicine Company only furnishes one product or a single class of products (e.g., durable medical equipment, genetic testing, diabetic supplies, or various prescription creams), potentially restricting a Practitioner’s treating options to a predetermined course of treatment.
**See Alert for full list of Suspect Characteristics
- Recommendation: The OIG encourages Practitioners to use heightened scrutiny, exercise caution and consider the above list of suspect criteria prior to entering into arrangements with Telemedicine Companies.
Blue Medicare Advantage Information
Transitions of Care Receipt of Discharge Information Quality Measure
According to a 2007 Journal of Hospital Medicine report, about half of all adults discharged from a hospital experience a medical error and approximately one in five of these suffer an adverse event.
The National Committee for Quality Assurance (NCQA) targets hospitals, medical health plans and providers for transitions of care measures to build the structures that safely coordinate patient care between in-patient and out-patient settings because these transitions are placing patients at risk for errors (Wheeler, 2022).
Completing follow-up education, confirming follow-up appointments and completing medication reconciliations post discharge all require physician offices to receive information about a hospital admission.
In 2022, Blue Medicare Advantage incentivized the Transitions of Care Receipt of Discharge Information quality measure to align with the Centers for Medicare and Medicaid Services (CMS). The goal is to collaborate and improve the networks that enable primary care physicians (PCP) offices to obtain hospitalization documentation, so they can act on it.
Closing the Quality Gap
Discharge information should be received within two calendar days of hospital discharge and may be included in a discharge summary, a summary of care record or in structured fields in an electronic medical record.
At a minimum, the discharge information content must include ALL of the following:
While there is ongoing education about this new measure, we know there may be lingering questions or clarity required to confirm what documentation is going to close the measure. Feel free to reach out to your provider engagement team to work with Blue KC on the process.
Consider working to provide documentation about hospitalizations in your existing networks and shared EMRs first. Next, consider how to expand the networks between existing networks and those outside facilities to augment supporting all patients’ safety through transitions of care.(References: Kripalani, S., Jackson, A. T., Schnipper, J. L., & Coleman, E. A. (2007). Promoting effective transitions of care at hospital discharge: a review of key issues for hospitalists. Journal of hospital medicine: an official
publication of the Society of Hospital Medicine, 2(5), 314-323. https://doi.org/10.1002/jhm.228; O'Neill, A. (2022, June 13). Transitions of care. NCQA. Retrieved August 31, 2022, from https://www.ncqa.org/hedis/measures/transitions-of-care/.
Updating and Certifying Provider Data in CMS’ National Plan & Provider Enumeration System
Blue KC wants to remind you to review your National Provider Identifier (NPI) data in the National Plan & Provider Enumeration System (NPPES) as soon as possible to ensure accurate provider data is displayed. As you may know, providers are legally required to keep their NPPES data current.
CMS is also encouraging Medicare Advantage Organizations to use NPPES as a resource for our online provider directories. By using NPPES, we can decrease the frequency by which we contact you for updated directory information and provide more reliable information to Medicare beneficiaries.
Advance Care Planning Vendor Update
Effective Advance Care Planning (ACP) is a valuable part of patient care and, as you know, it can be very time consuming. To support your team and give our members an opportunity to complete comprehensive ACP, Blue KC began partnering last year with Iris Healthcare, a specially trained ACP healthcare organization.
We want to update you that enrollment has closed for our Commercial and Medicare Advantage members whom we have identified would benefit from this FREE service. Iris Healthcare will work with these enrolled members for two years, with the option for these members to opt out at any time.
As a reminder, the Iris Healthcare ACP experts facilitate the discussions and generate Advance Directive documents with the member. Once completed, the documents can be shared with providers and facilities with the permission of the member. Clinicians may utilize completed documents from Iris for ACP consultation with our members, and submit the following ACP CPT codes for your time and service reviewing the signed Advance Directives:
|CPT 99497 (base code) – $86||Time-based code for initial 30-minutes of ACP discussions during a face-to-face encounter with patient and/or family member(s) / surrogate|
|CPT 99498 (add on) – $75||Time-based code for each additional 30-minutes of APC discussions during a face-to-face encounter with patient and/or family member(s) / surrogate|
What Iris Healthcare Does:
- Completes ACP conversations on behalf of care teams.
- Defers all specific treatment detail and patient questions to you.
- Coordinates family discussions and resolves family conflict or care disagreements.
- Meets quality measures and helps improve patient experience.
- Distributes ACP documents to you for your input and/or signature where appropriate, such as medical order for life-sustaining treatments.
What Iris Healthcare Does Not Do:
- Provide medical or nursing care.
- Suggest or advise a patient or family on care choices.
- Submit CPT codes or invoice the patient.
Prior Authorization Updates
Codes for Interventional Pain Management Procedures Will Move to eviCore
To streamline the clinical review process for Interventional Pain Management Procedures, Blue KC will be transitioning prior authorization over to eviCore, effective January 1, 2023.
Currently, eviCore administers prior authorization reviews for High-Tech Imaging and Cardiology for all lines of business. The additional codes that will now go to eviCore can be found in the table below. These codes will be the same for all lines of business (Commercial, Blue Medicare Advantage, ACA QHP and Small Group ACA). Some of these codes did not previously require a prior authorization, so providers are encouraged to become familiar with this change.
Note: Any procedures already authorized for dates of service prior to January 1, 2023 by Blue KC will remain in effect and will not need to be resubmitted to eviCore. Procedures that were not on the prior authorization list prior to January 1, 2023 WILL REQUIRE a prior authorization to be in place if the service will be performed on or after January 1, 2023.
|0213T||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||FACET JOINT|
|0214T||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||FACET JOINT|
|0215T||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||FACET JOINT|
|0216T||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||FACET JOINT|
|0217T||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||FACET JOINT|
|0218T||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||FACET JOINT|
|0228T||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|0229T||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|0230T||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|0231T||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|0274T||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||THERMAL INTRADISCAL|
|0275T||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||THERMAL INTRADISCAL|
|20550||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|20552||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||TRIGGER POINT INJECTION|
|20553||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||TRIGGER POINT INJECTION|
|22526||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||THERMAL INTRADISCAL|
|22527||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||THERMAL INTRADISCAL|
|23350||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|27096||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||SI JOINT|
|61790||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||STEREOTACTIC PROCEDURE|
|61791||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||STEREOTACTIC PROCEDURE|
|62287||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||DECOMPRESSION PROCEDURE|
|62310||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|62311||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|62318||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|62319||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|62320||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|62321||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|62322||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|62323||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|62324||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|62325||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|62326||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|62327||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|62350||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||DRUG PUMP|
|62351||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||DRUG PUMP|
|62355||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||REMOVAL|
|62360||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||DRUG PUMP|
|62361||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||DRUG PUMP|
|62362||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||DRUG PUMP|
|62365||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||REMOVAL|
|62367||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|62368||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|62369||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|62370||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|63650||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|63655||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|63661||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||REMOVAL|
|63662||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||REMOVAL|
|63663||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|63664||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|63685||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|63688||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||REMOVAL|
|64405||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||NERVE BLOCK|
|64445||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||NERVE BLOCK|
|64451||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||SI JOINT|
|64472||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||FACET JOINT|
|64479||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|64480||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|64483||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|64484||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||EPIDURAL STEROID|
|64490||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||FACET JOINT|
|64491||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||FACET JOINT|
|64492||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||FACET JOINT|
|64493||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||FACET JOINT|
|64494||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||FACET JOINT|
|64495||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||FACET JOINT|
|64510||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||REGIONAL SYMPATHETIC BLOCK|
|64520||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||REGIONAL SYMPATHETIC BLOCK|
|64581||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|64620||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||NERVE BLOCK|
|64622||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||SPINAL DENERVATION RFA|
|64625||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||SI JOINT|
|64626||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||SPINAL DENERVATION RFA|
|64633||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||SPINAL DENERVATION RFA|
|64634||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||SPINAL DENERVATION RFA|
|64635||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||SPINAL DENERVATION RFA|
|64636||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||SPINAL DENERVATION RFA|
|64999||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||SPINAL DENERVATION RFA|
|95970||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|95971||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|95972||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|95973||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|95974||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|95975||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|95978||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|95979||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|95980||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|95981||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|95982||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||ANALYSIS|
|95990||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||REFILL|
|95991||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||REFILL|
|C1767||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|C1778||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|C1787||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|C1816||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|C1820||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|C1883||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|C1897||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|E0783||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||DRUG PUMP|
|E0785||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||DRUG PUMP|
|E0786||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||DRUG PUMP|
|G0259||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||SI JOINT|
|G0260||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||SI JOINT|
|J1040||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||INJECTIONS||STEROID INJECTATE|
|L8680||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|L8681||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|L8682||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|L8683||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|L8685||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|L8686||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|L8687||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|L8688||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|L8689||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
|L8695||CPT/HCPCS||MSK||INTERVENTIONAL PAIN||SPINAL IMPLANT||NEUROSTIMULATOR IMPLANT|
SNF Waiver Extension of Prior Authorization
Blue KC wants to remind you the in-network Skilled Nursing Facilities’ (SNF) waiver of prior authorization for Commercial, Small Group ACA and Blue Medicare Advantage members will remain in place through the end of the public health emergency, which currently runs through October 13, 2022.
The waiver only applies to in-network SNF admissions from acute hospitals. Please check the Recent News Updates section on the home page of Providers.BlueKC.com for more details, as we continue to evaluate the success of this program and consider extending the waiver outside of the public health emergency period.
The codes below have been added to our prior authorization list, effective November 1, 2022, and continue to apply
|Code||Description||Effective date||Line of Business|
|43497||Incision of muscle of lower esophagus using an endoscope||11/1/2022||ACA and Commercial|
|15877||Suction Assisted removal of fat of body||11/1/2022||Commercial|
|0398T||Destruction of tissue of brain using MRI guidance||11/1/2022||Commercial|
|19328||Removal of intact breast implant||11/1/2022||Commercial|
Payment Policy Updates
Observation Care: POL-PP-126
Blue KC will have an updated payment policy for Observation Care that will impact all lines of business. Effective January 1, 2023, Blue KC will not reimburse for Observation Care that exceeds 72 hours.
For more details about this current payment policy, go to the log-in page at Providers.BlueKC.com and click on the Go to Payment Policies blue button. Scroll down and look under the heading, All Provider Payment and Coding Policies. The updated payment policy will be available to view on the Provider Portal beginning January 1, 2023.
JW Modifier Reminder
Effective September 1, 2022, Blue KC has a new payment policy POL-PP-234 for JW Modifier. This policy will allow us to be consistent across all lines of business, as the policy is already in place for Blue Medicare Advantage.
When the total volume of a single use/dose vial (SDV) of a drug or biological cannot be administered to a patient and unused quantity is appropriately discarded (i.e., drug wastage), the appropriate drug or biological code, along with the JW modifier, can be reported and is eligible for reimbursement, in addition to the amount of the drug administered up to the amount of the drug or biological as indicated on the SDV or package label.
Additional details include:
|The drug amount discarded/not administered to any patient||
|The Medical Record||
|Providers are expected to use the drug or biological in a responsible way to avoid drug wastage||
|When submitting a claim for a single use vial, packaged and dispensed for use on a single patient||
|When submitting a claim for a multi-dose vial||
|The units billed||
|Providers shall not charge, bill or collect a fee for drug wastage (modifier JW)||
This payment policy will be available to view on September 1, 2022. Go to the log-in page at Providers.BlueKC.com and click on Go To Payment Policies.
Medical Policy Updates
As announced in our August Provider Bulletin, Blue KC’s updated medical policies for elective total hip and total knee replacements will go into effect on October 3, 2022. To view these policies, visit Providers.BlueKC.com. After logging in, go to the Medical Policies section and select “Review Our Medical Policy”. Once you choose “I agree”, you’ll find the two policies under “Future Policy Updates”.
Key changes in these policies include:
|More specific definitions around what is required for conservative treatments prior to the surgery|
|Additional specific requirements for x-ray interpretations submitted|
|Clarifications around a maximal BMI permitted to gain approval for joint replacement|
Please also remember requests for an inpatient admission are reviewed separately after the initial review for the surgery. Elective joint replacements do not meet criteria for expedited status, so please provide sufficient time for review and decisions before scheduling these surgeries to avoid having to cancel and reschedule.
Finally, our new guidelines will require submitting orthopedic practices to obtain and submit all the pertinent records to prove requirements have been met. Statements saying “all requirements have been met” will no longer be accepted.
Pharmacy Policy Updates
Here are new Blue KC pharmacy polices that will require prior authorization and apply October 1, 2022:
|New Pharmacy Policies|
|Policy Number||Policy Name||Summary|
|5.01.794||Vonjo (pacritinib)||FDA Approved for myelofibrosis; Oral; Specialty pharmacy benefit|
|5.02.625||Korsuva (difelikefalin)||FDA approved for Chronic kidney disease associated pruritus, moderate to severe; IV; Medical-Rx benefit|
|5.02.626||Opdualag (nivolumab and relatlimab-rmbw)||FDA approved for Melanoma, unresectable or metastatic; IV; Medical-Rx benefit|
Partnering with You to Reduce ER Rates
Blue KC monitors aspects of continuity and coordination of medical care between care settings and initiates actions as needed to improve continuity. It is important to provide quality care and empathy towards each member. As the first contact in a member’s healthcare journey, communication and care coordination increase the overall healthcare outcome for the member.
ER rates have gone up and continue to remain high, even post-COVID, due to scheduling restraints with PCP and Specialists. The goals are to help reduce those ER rates by encouraging flexible scheduling and clinical triage to help improve the chances for a member to get an appointment in a timely manner.
When same day appointments are not available, offering alternative care through urgent care, telehealth or other outreach clinics eases the member’s concerns when dealing with illnesses, such as flu or coughs and colds.
|Blue KC’s powerful digital tool for providers can be accessed 24/7 with a click of a button! Experience our Provider Portal at Providers.BlueKC.com||
Provider Portal Features Include:
|NOT REGISTERED FOR THE PROVIDER PORTAL? CLICK ON "REGISTER NOW" ON THE LOG-IN PAGE!|
Your comments are welcome and can be sent to BlueSpeak@BlueKC.com. We would love to hear from you!
Please join the BlueSpeak email distribution list by signing into the Provider Portal and then selecting “Register for BlueSpeak eNewsletter” under “Provider Service Quick Links” on the home page.
If you have questions about any of these updates, please call the Blue KC Provider Hotline at 816-395-3929 for Commercial line of business, 866-508-7140 for Blue Medicare Advantage line of business or 866-859-3822 for the ACA Provider Hotline. We value and appreciate you as our partner in providing quality care.
An independent licensee of the Blue Cross and Blue Shield Association
© Blue Cross and Blue Shield of Kansas City. All rights reserved.